Clinical Operations
Clinical Project ManagementStudy Monitoring and Site ManagementTrial Master File and Document ManagementQuality and Vendor Management SystemsStudy DocumentsRegulatory Affairs
Regulatory StrategyRegulatory WritingAgency Communications and SubmissionsDocument Editorial, QC and SubmissionQC, Review and RedactionLegal RepresentationPharmacovigilanceILAP SubmissionsMedical Communications
Publication PlanningStrategic CommunicationsScientific CommunicationsMedical EducationMedical IllustrationGrant Applications and Project PartnershipProject responsibilities included:
Definition of objectives and audience
Development of core messaging
Selection of communication channels
Content creation
Collaboration with stakeholders
Monitor, adapt and legacy
The FRAILOMIC initiative was an international research project aimed at improving the understanding, diagnosis and management of frailty in older populations. Frailty, a condition characterized by increased vulnerability to stressors and reduced ability to perform daily activities, is a significant predictor of adverse outcomes such as hospitalisation, disability and mortality. The prevalence of frailty increases with age, making its early detection and management crucial in mitigating its progression to disability and associated healthcare burdens.
FRAILOMIC focused on identifying biomarkers—both clinical and laboratory-based—that could predict the risk of frailty, enhance its diagnostic accuracy and assess its prognosis. These biomarkers were expected to improve the clinical management of frailty by enabling earlier interventions and better prediction of outcomes such as disability and loss of independence.
The initiative was supported by a consortium of 20 institutions across nine countries, including universities, research centers and hospitals (and Niche). Key collaborators included institutions from Spain, the UK and other European nations. The project involved analyzing biomarkers from approximately 75,000 older individuals using advanced “omics” technologies, with samples drawn from diverse cohorts.
The initiative consisted of two phases: an exploratory phase to identify potential biomarkers and a validation phase to test their effectiveness in predicting, diagnosing and monitoring frailty. Ultimately, FRAILOMIC aimed to develop user-friendly clinical tools for healthcare providers to address frailty proactively, improving the quality of life for aging populations and reducing the healthcare burden associated with disability.
NST worked with FRAILOMIC to create an omnichannel dissemination package for an academic research program. This involved designing a coordinated communication strategy that leverages multiple platforms and media to share research findings effectively with diverse audiences. The goal is to ensure that the research impacts stakeholders such as academics, policymakers, practitioners and the public.